DK1664026T3 - Inhibitorer af mitotisk kinesin - Google Patents
Inhibitorer af mitotisk kinesinInfo
- Publication number
- DK1664026T3 DK1664026T3 DK04780791T DK04780791T DK1664026T3 DK 1664026 T3 DK1664026 T3 DK 1664026T3 DK 04780791 T DK04780791 T DK 04780791T DK 04780791 T DK04780791 T DK 04780791T DK 1664026 T3 DK1664026 T3 DK 1664026T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitors
- mitotic kinesin
- compounds
- ksp kinesin
- treating
- Prior art date
Links
- 102000010638 Kinesin Human genes 0.000 title abstract 3
- 108010063296 Kinesin Proteins 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title 1
- 230000000394 mitotic effect Effects 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical class C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ceramic Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Inorganic Chemistry (AREA)
- Structural Engineering (AREA)
- Materials Engineering (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49563703P | 2003-08-15 | 2003-08-15 | |
| US56358004P | 2004-04-19 | 2004-04-19 | |
| PCT/US2004/026012 WO2005019206A1 (en) | 2003-08-15 | 2004-08-11 | Mitotic kinesin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1664026T3 true DK1664026T3 (da) | 2009-05-04 |
Family
ID=34221386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04780791T DK1664026T3 (da) | 2003-08-15 | 2004-08-11 | Inhibitorer af mitotisk kinesin |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20060234984A1 (da) |
| EP (1) | EP1664026B1 (da) |
| JP (1) | JP4773961B2 (da) |
| AT (1) | ATE421512T1 (da) |
| AU (1) | AU2004266232B2 (da) |
| CA (1) | CA2534065A1 (da) |
| CY (1) | CY1108927T1 (da) |
| DE (1) | DE602004019229D1 (da) |
| DK (1) | DK1664026T3 (da) |
| ES (1) | ES2319429T3 (da) |
| HR (1) | HRP20090195T1 (da) |
| PL (1) | PL1664026T3 (da) |
| PT (1) | PT1664026E (da) |
| SI (1) | SI1664026T1 (da) |
| WO (1) | WO2005019206A1 (da) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60329756D1 (de) * | 2002-06-14 | 2009-12-03 | Merck & Co Inc | Mitotische kinesin-hemmer |
| CA2486215A1 (en) | 2002-06-14 | 2003-12-24 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| US20040248972A1 (en) * | 2003-05-16 | 2004-12-09 | Ambit Biosciences Corporation | Compounds and uses thereof |
| AU2004247023A1 (en) * | 2003-05-16 | 2004-12-23 | Ambit Biosciences Corporation | Heterocyclic compounds and uses thereof |
| US20050182125A1 (en) * | 2003-05-16 | 2005-08-18 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
| WO2005017190A2 (en) | 2003-08-15 | 2005-02-24 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| EP1656146A4 (en) | 2003-08-15 | 2009-04-15 | Merck & Co Inc | INHIBITORS OF MITOTIC KINESINE |
| PT1664026E (pt) * | 2003-08-15 | 2009-04-23 | Merck & Co Inc | Inibidores de cinesina mitótica |
| WO2005102996A2 (en) * | 2004-04-19 | 2005-11-03 | Merck & Co., Inc. | A process for the preparation of 2,2-disubstituted pyrroles |
| EP1765334A4 (en) | 2004-07-01 | 2008-02-06 | Merck & Co Inc | PRODRUGS OF INHIBITORS OF MITOTIC KINESINE |
| WO2006060737A2 (en) * | 2004-12-03 | 2006-06-08 | Takeda San Diego, Inc. | Mitotic kinesin inhibitors |
| JP2008533144A (ja) * | 2005-03-16 | 2008-08-21 | メルク エンド カムパニー インコーポレーテッド | 有糸分裂キネシン阻害剤 |
| ES2382814T3 (es) | 2005-05-17 | 2012-06-13 | Merck Sharp & Dohme Ltd. | Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer |
| MX2010004312A (es) | 2007-10-19 | 2010-07-05 | Schering Corp | Derivados de 1,3,4-tiadiazol espiro-condensados para inhibir la actividad de quinesina de la proteina de quinesina del huso. |
| GEP20166443B (en) | 2008-06-19 | 2016-03-10 | Takeda Pharmaceutical | Heterocyclic compound and use thereof |
| US8691825B2 (en) | 2009-04-01 | 2014-04-08 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
| BR112012008849A2 (pt) | 2009-10-14 | 2015-09-22 | Schering Corp | composto, composição farmacêutica, e, uso de um composto |
| US8999957B2 (en) | 2010-06-24 | 2015-04-07 | Merck Sharp & Dohme Corp. | Heterocyclic compounds as ERK inhibitors |
| US8518907B2 (en) | 2010-08-02 | 2013-08-27 | Merck Sharp & Dohme Corp. | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) |
| EP3587574B1 (en) | 2010-08-17 | 2022-03-16 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina) |
| WO2012030685A2 (en) | 2010-09-01 | 2012-03-08 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
| ES2663009T3 (es) | 2010-10-29 | 2018-04-10 | Sirna Therapeutics, Inc. | Inhibición de la expresión génica mediada por interferencia por ARN utilizando ácidos nucleicos de interferencia cortos (ANic) |
| US9351965B2 (en) | 2010-12-21 | 2016-05-31 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
| US9102671B2 (en) * | 2011-02-25 | 2015-08-11 | Novartis Ag | Compounds and compositions as TRK inhibitors |
| WO2013063214A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| US20150299696A1 (en) | 2012-05-02 | 2015-10-22 | Sirna Therapeutics, Inc. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
| BR112015006990A2 (pt) | 2012-09-28 | 2017-07-04 | Merck Sharp & Dohme | composto, composição farmacêutica, e, uso de pelo menos um composto |
| PL2925888T3 (pl) | 2012-11-28 | 2018-03-30 | Merck Sharp & Dohme Corp. | Kompozycje i sposoby do stosowania w leczeniu nowotworów |
| WO2014100065A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
| US9540377B2 (en) | 2013-01-30 | 2017-01-10 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as HDM2 inhibitors |
| US20160194368A1 (en) | 2013-09-03 | 2016-07-07 | Moderna Therapeutics, Inc. | Circular polynucleotides |
| CN104370939B (zh) * | 2014-10-14 | 2016-10-26 | 上海交通大学 | 一种手性二氢吡咯类化合物的制备方法 |
| JOP20190055A1 (ar) | 2016-09-26 | 2019-03-24 | Merck Sharp & Dohme | أجسام مضادة ضد cd27 |
| WO2018071283A1 (en) | 2016-10-12 | 2018-04-19 | Merck Sharp & Dohme Corp. | Kdm5 inhibitors |
| AU2018252546B2 (en) | 2017-04-13 | 2025-03-13 | Sairopa B.V. | Anti-SIRPα antibodies |
| WO2019094312A1 (en) | 2017-11-08 | 2019-05-16 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| EP3706742B1 (en) | 2017-11-08 | 2023-03-15 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
| WO2019148412A1 (en) | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anti-pd-1/lag3 bispecific antibodies |
| MX2021001486A (es) | 2018-08-07 | 2021-07-15 | Merck Sharp & Dohme Llc | Inhibidores prmt5. |
| EP3833668B1 (en) | 2018-08-07 | 2025-03-19 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
| US11981701B2 (en) | 2018-08-07 | 2024-05-14 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| AU2020408148B2 (en) | 2019-12-17 | 2025-04-24 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| EP4076459A4 (en) | 2019-12-17 | 2023-12-20 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
| US12441730B2 (en) | 2019-12-17 | 2025-10-14 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| AU2022328136A1 (en) | 2021-08-10 | 2023-11-30 | Abbvie Inc. | Nicotinamide ripk1 inhibitors |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3142699A (en) * | 1958-04-24 | 1964-07-28 | Bayer Ag | Urethane compounds and process therefor |
| US3635982A (en) * | 1969-04-08 | 1972-01-18 | American Home Prod | Amino-substituted-quinoxalinyloxazolidines and -oxazines |
| US4477389A (en) * | 1982-10-25 | 1984-10-16 | The United States Of America As Represented By The Secretary Of Agriculture | Polyhalogenated phenyl isocyanate synthesis with excess phosgene and either triethylamine or tetramethylurea |
| GB9206757D0 (en) | 1992-03-27 | 1992-05-13 | Ferring Bv | Novel peptide receptor ligands |
| US6057342A (en) * | 1996-08-16 | 2000-05-02 | Dupont Pharmaceutical Co. | Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
| CA2262117A1 (en) | 1996-08-16 | 1998-02-19 | The Dupont Merck Pharmaceutical Company | Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
| US6440686B1 (en) * | 2000-06-15 | 2002-08-27 | Cytokinetics, Inc. | Methods for screening and therapeutic applications of kinesin modulators |
| DE60232994D1 (de) * | 2001-12-06 | 2009-08-27 | Merck & Co Inc | Inhibitoren von mitotischem kinesin |
| JP2003177052A (ja) * | 2001-12-13 | 2003-06-27 | Takata Corp | シート重量計測装置 |
| ATE448207T1 (de) * | 2002-03-08 | 2009-11-15 | Merck & Co Inc | Mitotische kinesin-hemmer |
| WO2004039774A2 (en) * | 2002-05-23 | 2004-05-13 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| CA2483627A1 (en) * | 2002-05-23 | 2003-12-04 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| DE60329756D1 (de) * | 2002-06-14 | 2009-12-03 | Merck & Co Inc | Mitotische kinesin-hemmer |
| CA2486215A1 (en) * | 2002-06-14 | 2003-12-24 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| US6835899B2 (en) * | 2002-08-21 | 2004-12-28 | Trw Inc. | Load sensing assembly for a vehicle seat |
| US7235580B2 (en) * | 2002-10-18 | 2007-06-26 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| WO2004112699A2 (en) * | 2003-06-12 | 2004-12-29 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| JP4580932B2 (ja) * | 2003-06-12 | 2010-11-17 | メルク・シャープ・エンド・ドーム・コーポレイション | 有糸分裂キネシン阻害剤のプロドラッグ |
| EP1656140A4 (en) * | 2003-08-13 | 2009-03-04 | Merck & Co Inc | INHIBITORS OF MITOTIC KINESINE |
| WO2005017190A2 (en) * | 2003-08-15 | 2005-02-24 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| PT1664026E (pt) * | 2003-08-15 | 2009-04-23 | Merck & Co Inc | Inibidores de cinesina mitótica |
| PE20050730A1 (es) * | 2003-08-15 | 2005-09-20 | Merck & Co Inc | Derivados de 2,5-dihidropirrol 2,2-disustituidos como inhibidores de quinesinas mitoticas |
| US7294640B2 (en) * | 2004-02-06 | 2007-11-13 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
-
2004
- 2004-08-11 PT PT04780791T patent/PT1664026E/pt unknown
- 2004-08-11 AT AT04780791T patent/ATE421512T1/de active
- 2004-08-11 PL PL04780791T patent/PL1664026T3/pl unknown
- 2004-08-11 DK DK04780791T patent/DK1664026T3/da active
- 2004-08-11 DE DE602004019229T patent/DE602004019229D1/de not_active Expired - Lifetime
- 2004-08-11 CA CA002534065A patent/CA2534065A1/en not_active Abandoned
- 2004-08-11 US US10/567,676 patent/US20060234984A1/en not_active Abandoned
- 2004-08-11 AU AU2004266232A patent/AU2004266232B2/en not_active Ceased
- 2004-08-11 ES ES04780791T patent/ES2319429T3/es not_active Expired - Lifetime
- 2004-08-11 WO PCT/US2004/026012 patent/WO2005019206A1/en not_active Ceased
- 2004-08-11 JP JP2006523332A patent/JP4773961B2/ja not_active Expired - Fee Related
- 2004-08-11 US US10/915,743 patent/US7465746B2/en not_active Expired - Fee Related
- 2004-08-11 HR HR20090195T patent/HRP20090195T1/xx unknown
- 2004-08-11 SI SI200431039T patent/SI1664026T1/sl unknown
- 2004-08-11 EP EP04780791A patent/EP1664026B1/en not_active Expired - Lifetime
-
2009
- 2009-03-30 CY CY20091100367T patent/CY1108927T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1664026B1 (en) | 2009-01-21 |
| CA2534065A1 (en) | 2005-03-03 |
| AU2004266232B2 (en) | 2008-07-03 |
| WO2005019206A1 (en) | 2005-03-03 |
| PL1664026T3 (pl) | 2009-06-30 |
| AU2004266232A1 (en) | 2005-03-03 |
| US20050043357A1 (en) | 2005-02-24 |
| SI1664026T1 (sl) | 2009-04-30 |
| US20060234984A1 (en) | 2006-10-19 |
| US7465746B2 (en) | 2008-12-16 |
| JP2007502774A (ja) | 2007-02-15 |
| PT1664026E (pt) | 2009-04-23 |
| CY1108927T1 (el) | 2014-07-02 |
| HRP20090195T1 (hr) | 2009-05-31 |
| EP1664026A1 (en) | 2006-06-07 |
| DE602004019229D1 (de) | 2009-03-12 |
| JP4773961B2 (ja) | 2011-09-14 |
| ATE421512T1 (de) | 2009-02-15 |
| ES2319429T3 (es) | 2009-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1664026T3 (da) | Inhibitorer af mitotisk kinesin | |
| ATE446094T1 (de) | Mitotische kinesin-hemmer | |
| ATE448207T1 (de) | Mitotische kinesin-hemmer | |
| EP1515949A4 (en) | INHIBITORS OF MITOTIC KINESINE | |
| ATE424388T1 (de) | Mitotische kinesinhemmer | |
| ATE447577T1 (de) | Mitotische kinesin-hemmer | |
| EP1463733A4 (en) | INHIBITORS OF MITOTIC KINESINE | |
| WO2005017190A3 (en) | Mitotic kinesin inhibitors | |
| WO2005018547A3 (en) | Mitotic kinesin inhibitors | |
| WO2004037171A3 (en) | Mitotic kinesin inhibitors | |
| WO2004039774A3 (en) | Mitotic kinesin inhibitors | |
| WO2003099211A3 (en) | Mitotic kinesin inhibitors | |
| WO2005065183A3 (en) | Mitotic kinesin inhibitors | |
| WO2006068933A3 (en) | Mitotic kinesin inhibitors | |
| NO20070589L (no) | Mitotiske kinesin-inhibitorer. | |
| WO2005060654A3 (en) | Mitotic kinesin inhibitors | |
| ATE426605T1 (de) | Inhibitoren von mitotischem kinesin | |
| WO2006007496A3 (en) | Mitotic kinesin inhibitors | |
| WO2006007501A3 (en) | Mitotic kinesin inhibitors | |
| WO2006023440A3 (en) | Mitotic kinesin inhibitors | |
| WO2004087050A3 (en) | Mitotic kinesin inhibitors |